Found: 5
Select item for more details and to access through your institution.
Targeting IFN activity to both B cells and plasmacytoid dendritic cells induces a robust tolerogenic response and protection against EAE.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-00891-6
- By:
- Publication type:
- Article
Interleukin-1 as Innate Mediator of T Cell Immunity.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.621931
- By:
- Publication type:
- Article
A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01908-6
- By:
- Publication type:
- Article
Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00211-5
- By:
- Publication type:
- Article
Rethinking IL-1 Antagonism in Respiratory Viral Infections: A Role for IL-1 Signaling in the Development of Antiviral T Cell Immunity.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 21, p. 15770, doi. 10.3390/ijms242115770
- By:
- Publication type:
- Article